Patriot Financial Group Insurance Agency’s DiaMedica Therapeutics DMAC Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,300	Closed	-$2K	–	792
2022 Q2	$2K	Hold	1,300	–	–	﹤0.01%	1738
2022 Q1	$3K	Hold	1,300	–	–	﹤0.01%	1755
2021 Q4	$4K	Hold	1,300	–	–	﹤0.01%	1766
2021 Q3	$5K	Sell	1,300 -1,000	-43%	-$3.83K	﹤0.01%	1685
2021 Q2	$10K	Sell	2,300 -6,903	-75%	-$56.6K	﹤0.01%	1435
2021 Q1	$84K	Buy	+9,203	New	+$86K	0.02%	610
2020 Q2	–	Sell	-2,750	Closed	-$8K	–	1683
2020 Q1	$8K	Hold	2,750	–	–	﹤0.01%	911
2019 Q4	$13K	Buy	2,750 +750	+38%	+$2.33K	﹤0.01%	776
2019 Q3	$4K	Hold	2,000	–	–	﹤0.01%	972
2019 Q2	$10K	Sell	2,000 -1,000	-33%	-$3.46K	﹤0.01%	799
2019 Q1	$14K	Buy	+3,000	New	+$10.8K	0.01%	628

Other funds holding DMAC

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Patriot Financial Group Insurance Agency's DMAC Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of DiaMedica Therapeutics (DMAC) in Q3 2022, closing a stake of 1,300 shares — an estimated $2K sold.

Patriot Financial Group Insurance Agency first reported a position in DMAC in Q1 2019 and held it in 11 quarters. The position peaked at $84K in Q1 2021. 26 funds tracked by Wall St. Rank hold DMAC as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining DiaMedica Therapeutics position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 1,300 DiaMedica Therapeutics shares in Q3 2022, an estimated $2K.
Patriot Financial Group Insurance Agency first reported a position in DiaMedica Therapeutics in Q1 2019 and held it in 11 quarters.
Patriot Financial Group Insurance Agency's DiaMedica Therapeutics position peaked at $84K in Q1 2021.
26 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.